Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
LOUISVILLE, Ky., Feb. 22, 2016 -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the Texas State Board of Pharmacy (TSBP) has signed an agreement to adopt Appriss' Prescription Drug Monitoring Solution, PMP AWARxE, to improve patient safety, combat prescription drug abuse and drug diversion.
Prescription Monitoring Programs (PMPs) are state-run programs that track the distribution of narcotics and other prescriptions for federally controlled substances. PMP AWARxE provides access to mandatory pharmacy reporting and offers secure accessibility to data across state lines.
"Appriss is proud to support the TSBP in the promotion of patient safety," said Krishnan Sastry, Executive Vice President of Appriss. "There is a definite evolution of focus of the prescription monitoring programs from solely being a vehicle for surveillance and law enforcement to one that helps identify patients at risk for opioid abuse and finding them the help they need. PMPs can serve as a core foundation in that mission to improve patient safety and fight addiction."
The TSBP will implement the HIPAA-compliant PMP platform in the fall of 2016 and joins 24 other states in adopting an Appriss prescription monitoring solution nationally.
About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.
For more information, visit www.appriss.com (http://www.appriss.com).
CONTACT: Kathy Sue Bennett
Marketing Manager
Appriss, Inc.
[email protected]
